← Insider buys

ICVX

Icosavax, Inc.

No insider bought or sold Icosavax, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo

ICVX over the last year

Prices for ICVX aren't in yet.

ICVX after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

32 insider filings since 2021, newest first

ICVXSell

Adam K. Simpson · CEO

$229K−1.0%Feb 2
ICVXSell

Niranjan Kanesa-Thasan · Chief Medical Officer

$1.7M−32.0%Jan 5
ICVXSell

Adam K. Simpson · CEO

$235K−1.0%Jan 4
ICVXSell

Adam K. Simpson · CEO

$2.4M−13.0%Dec 22
ICVXSell

Thomas Joseph Russo · CFO

$235K−29.0%Dec 22
ICVXSell

Niranjan Kanesa-Thasan · Chief Medical Officer

$184K−5.0%Dec 22
ICVXSell

Cassia Cearley · Chief Business Officer

$123K−6.0%Dec 22
ICVXSell

Cassia Cearley · Chief Business Officer

$140K−6.0%Dec 15
ICVXSell

Niranjan Kanesa-Thasan · Chief Medical Officer

$29K−1.0%Aug 1
ICVXSell

Thomas Joseph Russo · CFO

$27K−6.0%Aug 1
ICVXSell

Adam K. Simpson · CEO

$104K−1.0%Aug 1
ICVXSell

Douglas Holtzman · Chief Scientific Officer

$145K−5.0%Jul 3
ICVXSell

Cassia Cearley · Chief Business Officer

$100K−7.0%May 25
ICVXSell

Douglas Holtzman · Chief Scientific Officer

$124K−7.0%Apr 5
ICVXSell

Cassia Cearley · Chief Business Officer

$39K−3.0%Mar 8
ICVXSell

Elizabeth Bekiroglu · GC, Corp. Sec.

$63K−5.0%Feb 15
ICVXSell

Adam K. Simpson · CEO

$80K−1.0%Feb 15
ICVXSell

Douglas Holtzman · Chief Scientific Officer

$50K−2.0%Feb 15
ICVXSell

Adam K. Simpson · CEO

$598K−6.0%Dec 23
ICVXSell

Douglas Holtzman · Chief Scientific Officer

$219K−6.0%Dec 16
ICVXSell

Adam K. Simpson · CEO

$77K−1.0%Aug 2
ICVXSell

Douglas Holtzman · Chief Scientific Officer

$69K−3.0%Aug 2
ICVXBuy

Mark Mcdade · Director

$300K+1.0%Apr 5
ICVXBuy

Ra Capital Management, L.P. · Director and 10% owner

$837K+3.0%Mar 30
ICVXSell

Cassia Cearley · Chief Business Officer

$172K−9.0%Mar 9
ICVXBuy

Ra Capital Management, L.P. · Director and 10% owner

$40.0M−131.0%Aug 4
ICVXBuy

Nanodimension Iii, L.P. · Former 10% Owner

$2.0M+5.0%Aug 4
ICVXBuy

Terry P Gould · Director

$2.0M+108.0%Aug 3
ICVXBuy

Adams Street Partners LLC · Former 10% Owner

$2.0M+108.0%Aug 3
ICVXBuy

Sanofi · 10% owner

$1.0M+2.0%Aug 2
ICVXBuy

Qiming U.S. Healthcare Fund Ii, L.P. · Former 10% Owner

$3.3M+7.0%Aug 2
ICVXBuy

Niranjan Kanesa-Thasan · Chief Medical Officer

$100K+4.0%Aug 2

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.